Sangamo Therapeutics
SGMO
#9296
Rank
ยฃ78.78 M
Marketcap
ยฃ0.19
Share price
-0.55%
Change (1 day)
-61.28%
Change (1 year)

Sangamo Therapeutics (SGMO) - Net assets

Net assets on the balance sheet as of September 2025 : ยฃ4.66 Million

According to Sangamo Therapeutics 's latest financial reports the company has ยฃ4.66 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sangamo Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$ยฃ18.14 M-72.11%
2023-12-31$ยฃ65.06 M-73.31%
2022-12-31$ยฃ0.24 B-12.32%
2021-12-31$ยฃ0.27 B-23.79%
2020-12-31$ยฃ0.36 B10.57%
2019-12-31$ยฃ0.33 B14.06%
2018-12-31$ยฃ0.28 B108.1%
2017-12-31$ยฃ0.13 B25.96%
2016-12-31$ยฃ0.11 B-15%
2015-12-31$ยฃ0.12 B-2.16%
2014-12-31$ยฃ0.13 B79.87%
2013-12-31$ยฃ73.78 M83.77%
2012-12-31$ยฃ40.15 M-22.12%
2011-12-31$ยฃ51.55 M42.36%
2010-12-31$ยฃ36.21 M-18.36%
2009-12-31$ยฃ44.35 M17.36%
2008-12-31$ยฃ37.79 M4.11%
2007-12-31$ยฃ36.3 M46%
2006-12-31$ยฃ24.86 M13.39%
2005-12-31$ยฃ21.92 M30.02%
2004-12-31$ยฃ16.86 M-32.45%
2003-12-31$ยฃ24.96 M-26.2%
2002-12-31$ยฃ33.83 M-40.43%
2001-12-31$ยฃ56.79 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
ยฃ60.88 B 1,306,066.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.46 B 138,583.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ13.63 B 292,336.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
ยฃ13.08 B 280,566.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ16.88 B 362,193.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ39.32 B 843,436.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.58 B 12,540.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ4.54 B 97,401.20%๐Ÿ‡บ๐Ÿ‡ธ USA